Glia, including astrocytes, microglia and oligodendrocytes, are important components that maintain the architecture of the brain and in many ways contribute to the proper functioning of neurons. Glial cells vastly outnumber neurons in the brain and independently control several crucial brain functions. Impaired glial cells are the cause of several diseases, and pharmacological targeting to repair damaged glia will enable functional recovery in patients suffering from devastating neurological disorders. The interaction between glial cells and some patrolling immune cells in the brain comprise the brain-specific immune system that protects the brain from extraneous agents and repairs injured tissue. While this system can cope with minor insults and infections, when faced with significant challenges such as AIDS dementia, multiple sclerosis, Huntington's disease, Parkinson's disease, etc., an effective and balanced immune response that facilitates repair and protection is found wanting. Several debilitating neurological disorders are often associated with dysfunctional glial cells that have limited ability to repair the injured brain and even promote brain damage. In this discussion, specific signaling pathways in glia that are affected in AIDS dementia and periventricular white matter injury will be highlighted.
TAT blocks Wnt in astrocytes to induce HAND
Can a 'serine' , in place of a 'cysteine' , induce changes powerful enough to cause human immunodeficiency virus (HIV)-associated neurocognitive disorder (HAND) or HIVassociated dementia (HAD)? Data obtained from a recent study [1] , in corroboration with earlier results [2] , seems to support this conclusion. Indeed, the result of this substitution causes sufficient molecular and physiological effects that lead to HAND/HAD. Over the years several pathways have been identified that HIV-1 sabotages to its advantage thereby rendering the host immune system compromised.
The Wnt/β-catenin pathway is one of these pathways. In astrocytes, this protein complex, that regulates several different genes, seems to be involved in the host defense against HIV-1 replication [1] . HIV-1 has cleverly found a way to with low density lipoprotein receptor-related protein (LRP), mediates the internalization of Tat inside the cells, which retains the capacity to transactivate viral and/or cellular genes [3] .
From the perspective of the present study, HIV-1 Tat demonstrates strong monocyte chemotactic properties and an increased migration of monocytes to the brain, which is strongly correlated with HAND [2] .
Interestingly, mutations in Tat seem to account for the difference in the effect of Tat protein in astrocytes, predominantly, the effect on dementia. Earlier work in the area of HAND/ HAD revealed that the incidence of HAND/HAD in countries such as India was relatively low (about 1-2%) in comparison to the prevalence in North America and Europe that has been estimated at 15-30% [2] . Strikingly, the authors looked at the role of the Tat protein encoded by different HIV-1 clades since western nations harbored the HIV-1 clade B subtype, while in India the predominant subtype was clade C.
Importantly, the authors revealed that the Tat protein, which has monocytic chemotactic function, showed important differences between subtypes. Cysteine (at position 31) was highly (>99%) conserved in non-subtype C viruses and more than 90% of subtype C viruses encoded a serine at this position. In fact, a variant strain, with a serine instead of a cysteine, possessed transactivation property of Tat, but was defective for chemotactic activity, which is key to the progression of HAND [2] .
Progressing from this finding over a decade ago, the present study [1] While the astrocyte is an important glial cell that has now gained substantial attention to its numerous roles in diseases and homeostasis of the CNS, another glial cell that also contributes to both pathology and normal brain development is the microglia [5] . Of hematopoietic origin (unlike the neuroectodermal origin of astrocytes), microglia release several neurotoxic factors upon HIV-1 infection and is an important HIV-1 reservoir in the CNS [4] .
While it is known that Wnt-3a stimulation of microglia leads to enhanced expression of proinflammatory genes through the stabilization of β-catenin [6] , there is no evidence for the effect of HIV-1 on the Wnt/β-catenin pathway in microglia and the findings of Henderson et al. [19] ) and primary mouse microglia [16] and as well, morphine may activate multiple pathways to induce neuroinflammation. In light of findings that opioid activation of TLR-4 contributes to neuroinflammation [9] , it could also be speculated that S. pneumoniae infection drives a pan-TLR response that is potentiated by morphine. Using an MOR-null mouse as well as MOR antagonists, Dutta et al.
show that morphine increased TLR expression in microglia, suggesting that this is a MORdependent process [16] . Previously, they have shown that morphine impairs TLR-9-NF-kB signaling and diminishes bacterial clearance in resident alveolar macrophages [19] . These [23] . Precursors enter the developing brain and differentiate into microglia which guide invading vasculature to establish blood circulation in the developing CNS, in addition to its other functions [22] .
Microglial progenitor cells that colonize the CNS during development might differentiate into amoeboid microglia [22] . Amoeboid microglia refers to microglial cells that penetrate the brain during early development, express surface antigens similar to, and share morphology and function with activated macrophages [22] . They can phagocytose cellular debris that arise during brain development and trim axonal projections and synapses; the latter process termed synaptic stripping [24] , a part of a normal structural development of the CNS. Amoeboid microglia perhaps also transform into a ramified form with long processes as development proceeds, where the decrease in number of amoeboid microglia correlates to the increase in ramified microglia [22] . Rathnasamy et al. [25] show that hypoxia reduces the levels of the antioxidant enzyme, glutathione (GSH), in oligodendrocytes, making them vulnerable to hypoxia-induced death by free radical-mediated mechanisms.
Along with death of oligodendrocytes, conditioned medium from hypoxic microglia also blocked oligodendrocyte proliferation, due to the pro-inflammatory cytokine, IL-1b [25] . Indeed, high levels of iron have been [27] . Unfortunately, contrasting results in mouse models also contributed to the discrepancies and currently there seem to be no active clinical trials with Desferal. The paper by Rathnasamy et al. [25] provides a mechanistic approach to the problem of iron overload in the CNS, which has also been suggested to be the instigator of MS neuropathogenesis. Recent controversial treatments for MS, such as balloon angioplasty is based on the hypothesis that MS is caused due to constriction of the neck veins leading to increase in iron load in the CNS [29] .
In the light of these findings in MS patients, the study by Rathnasamy et al. [25] sheds light on iron-mediated neuropathogenesis since microglia seem to be the culprits, wherein iron from hypoxic microglia cause neonatal rat periventricular white matter damage through the production of pro-inflammatory cytokines and reactive oxygen/nitrogen species. In fact, in this study, it was found that the levels of iron in oligodendrocytes was low and did not contribute to the pathogenesis. Thus, the finding that amoeboid microglia accumulate iron during hypoxia and produce free radicals and pro-inflammatory cytokines, causing oligodendrocyte death, may underlie the mechanism of PWMI [25] . This study has important implications not only for the role of microglia in iron-mediated neuropathogenesis but also has far reaching implications in neurodegenerative diseases of the white matter. 
Conclusion

